RedHill Biopharma Ltd. (NASDAQ:RDHL) shareholders are probably feeling a little disappointed, since its shares fell 3.9% to US$2.74 in the week after its latest quarterly results. Revenues of US$22m came in a modest 7.7% below forecasts. Statutory losses were a relative bright spot though, with a per-share loss of US$0.05 […]
Biopharma
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Senior Vice President and Chief Commercial Officer On February 28, 2022, CTI BioPharma Corp. (the “Company” or “CTI”) appointed James K. Fong as the Company’s Senior Vice President […]